Cwm Position In Dexcom (DXCM) Was Has Lifted; Bridger Management Has Upped Medicines Co (MDCO) Position

The Medicines Company (NASDAQ:MDCO) Logo

Cwm Llc increased its stake in Dexcom Inc (DXCM) by 25.82% based on its latest 2018Q4 regulatory filing with the SEC. Cwm Llc bought 6,704 shares as the company’s stock rose 13.47% with the market. The institutional investor held 32,670 shares of the health care company at the end of 2018Q4, valued at $3.91 million, up from 25,966 at the end of the previous reported quarter. Cwm Llc who had been investing in Dexcom Inc for a number of months, seems to be bullish on the $13.59B market cap company. The stock increased 2.83% or $4.15 during the last trading session, reaching $151. About 3.07 million shares traded or 141.93% up from the average. DexCom, Inc. (NASDAQ:DXCM) has risen 161.89% since March 17, 2018 and is uptrending. It has outperformed by 157.52% the S&P500. Some Historical DXCM News: 28/03/2018 – DEXCOM INC DXCM.O : BMO RAISES TARGET PRICE TO $78 FROM $68; 02/05/2018 – DEXCOM 1Q LOSS/SHR 28C, EST. LOSS/SHR 33C; 27/03/2018 – Dexcom Glucose Monitoring System, Dexcom G6, Gets FDA Approval; 20/04/2018 – DJ DexCom Inc, Inst Holders, 1Q 2018 (DXCM); 27/03/2018 – U.S. FDA SAYS AUTHORIZATION OF ICGM SYSTEM CLASSIFIES THIS NEW TYPE OF DEVICE IN CLASS Il & SUBJECTS IT TO CERTAIN CRITERIA CALLED SPECIAL CONTROLS; 07/05/2018 – TERUMO, DEXCOM FORM EXCLUSIVE JAPAN SALE PACT FOR CGM; 08/03/2018 – WaveForm: Patent Trial and Appeal Board Rulles Two Early Patents Aren’t Invalid, Based on Challenges by Dexcom Inc; 09/04/2018 – DexCom Forms Golden Cross: Technicals; 08/03/2018 – CORRECTED-WAVEFORM TECHNOLOGIES (NOT DEXCOM INC) – PTAB RULED 2 EARLY PATENTS HELD BY WAVEFORM ARE NOT INVALID, BASED ON CHALLENGES BROUGHT BY DEXCOM; 29/03/2018 – Alger Spectra Adds DexCom, Cuts CBS, Buys More Facebook

Bridger Management Llc increased its stake in Medicines Co (MDCO) by 30.82% based on its latest 2018Q4 regulatory filing with the SEC. Bridger Management Llc bought 720,981 shares as the company’s stock rose 20.76% with the market. The hedge fund held 3.06 million shares of the major pharmaceuticals company at the end of 2018Q4, valued at $58.58M, up from 2.34 million at the end of the previous reported quarter. Bridger Management Llc who had been investing in Medicines Co for a number of months, seems to be bullish on the $2.00B market cap company. The stock increased 3.59% or $0.94 during the last trading session, reaching $27.13. About 1.52 million shares traded or 19.65% up from the average. The Medicines Company (NASDAQ:MDCO) has declined 22.18% since March 17, 2018 and is downtrending. It has underperformed by 26.55% the S&P500. Some Historical MDCO News: 28/03/2018 – KINGWORLD MEDICINES GROUP LTD – FY REVENUE DECREASED BY 2.1% TO RMB1.03 BLN; 29/03/2018 – SHIRE PLC ANNOUNCED EUROPEAN MEDICINES AGENCY HAS VALIDATED ITS MARKETING AUTHORIZATION APPLICATION FOR LANADELUMAB (SHP643); 03/04/2018 – ASTRAZENECA PLC – EUROPEAN MEDICINES AGENCY ACCEPTS REGULATORY SUBMISSION FOR LYNPARZA IN BRCA-MUTATED, HER2-NEGATIVE METASTATIC; 07/05/2018 – Medicines Co: Phase III Trials of Inclisiran Progressing as Planned With No Material Safety Observations; 23/03/2018 – CHINA NATIONAL ACCORD MEDICINES 000028.SZ SAYS WALGREENS BOOSTS ALLIANCE (HONG KONG) INVESTMENTS LTD GETS CHINA COMMERCE MINISTRY’S APPROVAL TO ACQUIRE COMPANY’S UNIT; 13/03/2018 – CSL CEO Paul Perreault Calls on Industry to Improve Patients’ Access to Medicines; 01/05/2018 – BioCryst Receives European Medicines Agency Approval for ALPIVAB for the Treatment of Influenza; 13/03/2018 – ROCHE CEO SCHWAN CONFIRMS EXPECTS SALES OF NEW MEDICINES TO COMPENSATE OR OVERCOMPENSATE FOR FALLING REVENUE FROM PATENT-EXPIRED DRUGS FACING COMPETITION FROM BIOSIMILARS; 27/03/2018 – Homology Medicines Announces Pricing of Initial Public Offering; 23/04/2018 – Homology Medicines to Participate in the World Orphan Drug Congress

Since September 24, 2018, it had 0 insider buys, and 28 insider sales for $20.83 million activity. Shares for $245,129 were sold by DOUBLEDAY RICHARD on Monday, September 24. ALTMAN STEVEN R sold $339,134 worth of stock. 5,000 shares were sold by Balo Andrew K, worth $623,934 on Friday, October 12. Shares for $627,294 were sold by ACE HEATHER S. 3,114 DexCom, Inc. (NASDAQ:DXCM) shares with value of $439,841 were sold by Pacelli Steven Robert. Leach Jacob Steven sold 47,600 shares worth $6.85 million.

Investors sentiment increased to 1.47 in Q4 2018. Its up 0.16, from 1.31 in 2018Q3. It is positive, as 34 investors sold DXCM shares while 99 reduced holdings. 76 funds opened positions while 119 raised stakes. 85.42 million shares or 1.55% more from 84.12 million shares in 2018Q3 were reported. The California-based Dowling Yahnke Ltd Com has invested 0.74% in DexCom, Inc. (NASDAQ:DXCM). Marco Investment Mgmt Ltd Liability Com reported 2,000 shares. Timessquare Capital Mngmt Ltd, a New York-based fund reported 478,600 shares. Eqis Capital invested in 13,077 shares or 0.12% of the stock. Stevens Capital Mgmt Limited Partnership owns 39,763 shares for 0.25% of their portfolio. Guggenheim Lc holds 0.06% or 58,033 shares in its portfolio. Tci Wealth Inc has 0% invested in DexCom, Inc. (NASDAQ:DXCM) for 8 shares. Synovus Fincl stated it has 12 shares. Artisan Partners Partnership accumulated 0.18% or 678,562 shares. Apg Asset Management Nv accumulated 0% or 13,600 shares. Stone Ridge Asset Lc invested in 1,874 shares. Neuberger Berman Group Inc Limited Liability Com owns 0.02% invested in DexCom, Inc. (NASDAQ:DXCM) for 133,947 shares. Mirae Asset Investments Co holds 0.08% or 75,636 shares. Eulav Asset has 66,000 shares for 0.39% of their portfolio. Earnest Prtnrs Limited Liability Corp accumulated 33 shares.

More notable recent DexCom, Inc. (NASDAQ:DXCM) news were published by: Nasdaq.com which released: “Here’s Why You Should Invest in Illumina (ILMN) Stock Now – Nasdaq” on February 25, 2019, also Nasdaq.com with their article: “Here’s Why Investors Should Bet on DexCom (DXCM) Right Now – Nasdaq” published on January 03, 2019, Fool.com published: “Is DexCom a Buy? – Motley Fool” on March 08, 2019. More interesting news about DexCom, Inc. (NASDAQ:DXCM) were released by: Seekingalpha.com and their article: “DexCom Q4 2018 Earnings Preview – Seeking Alpha” published on February 20, 2019 as well as Nasdaq.com‘s news article titled: “DexCom (DXCM) Q4 Earnings and Revenues Top Estimates – Nasdaq” with publication date: February 21, 2019.

Cwm Llc, which manages about $1.90 billion and $4.00B US Long portfolio, decreased its stake in Ishares Tr (IWO) by 5,318 shares to 20,027 shares, valued at $3.36 million in 2018Q4, according to the filing. It also reduced its holding in Ebay Inc (NASDAQ:EBAY) by 72,011 shares in the quarter, leaving it with 251,310 shares, and cut its stake in Ishares Tr (HEWJ).

Bridger Management Llc, which manages about $3.11B and $1.20B US Long portfolio, decreased its stake in Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) by 64,225 shares to 658,785 shares, valued at $48.03M in 2018Q4, according to the filing. It also reduced its holding in Post Hldgs Inc (NYSE:POST) by 215,986 shares in the quarter, leaving it with 709,796 shares, and cut its stake in Wright Med Group N V.

More notable recent The Medicines Company (NASDAQ:MDCO) news were published by: Nasdaq.com which released: “Noteworthy Wednesday Option Activity: MDCO, PEG, THO – Nasdaq” on March 06, 2019, also Seekingalpha.com with their article: “Medicines Q4 2018 Earnings Preview – Seeking Alpha” published on February 26, 2019, Seekingalpha.com published: “Medicines beats by $0.02 – Seeking Alpha” on February 27, 2019. More interesting news about The Medicines Company (NASDAQ:MDCO) were released by: Nasdaq.com and their article: “Monday 3/11 Insider Buying Report: MDCO, STBA – Nasdaq” published on March 11, 2019 as well as Nasdaq.com‘s news article titled: “Medicines Company (MDCO) Q4 Loss Widens, Inclisiran in Focus – Nasdaq” with publication date: February 28, 2019.

Investors sentiment increased to 1.76 in Q4 2018. Its up 0.68, from 1.08 in 2018Q3. It is positive, as 23 investors sold MDCO shares while 36 reduced holdings. 38 funds opened positions while 66 raised stakes. 89.79 million shares or 2.48% more from 87.62 million shares in 2018Q3 were reported. Moreover, Rhenman Prns Asset Mngmt has 0.3% invested in The Medicines Company (NASDAQ:MDCO) for 135,000 shares. Fmr Lc holds 0.03% in The Medicines Company (NASDAQ:MDCO) or 11.08 million shares. State Of Tennessee Treasury Department invested in 28,624 shares. Citigroup Inc stated it has 0% of its portfolio in The Medicines Company (NASDAQ:MDCO). Chicago Equity Lc holds 0.05% of its portfolio in The Medicines Company (NASDAQ:MDCO) for 58,720 shares. Maverick Cap Limited has invested 0.99% of its portfolio in The Medicines Company (NASDAQ:MDCO). First Midwest State Bank Division has 0.19% invested in The Medicines Company (NASDAQ:MDCO). Hudson Bay Capital Management Limited Partnership holds 49,300 shares or 0.01% of its portfolio. Credit Suisse Ag accumulated 56,075 shares. Premier Asset Mngmt reported 25,248 shares. Tiaa Cref Investment Limited invested in 0% or 167,655 shares. Fosun accumulated 34,000 shares or 0.04% of the stock. Jane Street Gru Limited Company, a New York-based fund reported 97,368 shares. National Bank Of Mellon invested in 785,583 shares or 0% of the stock. Moreover, Aperio Gp Ltd Llc has 0% invested in The Medicines Company (NASDAQ:MDCO).

DexCom, Inc. (NASDAQ:DXCM) Institutional Positions Chart